The startup is expanding its services less than one year after it started offering compounded GLP-1 weight loss drugs.

Published results showed patients with obesity who took anti-obesity medications and had postoperative weight loss within 1 year after total joint arthroplasty may be at significantly decreased risk ...

WEIGHT loss jabs could raise the risk of a “potentially blinding condition” known as an “eye stroke”, researchers have warned ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels. Because of outsized demand for ...

Novo Nordisk's (NVO) weight loss therapy Wegovy/Ozempic come out of shortage, but the FDA won't crack down on compounders ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Ever wonder how celebrities always seem red carpet ready? Melanie Speed of Flawless Med Spa shares some insight.

The U.S. FDA announced Friday that it would refrain from penalizing makers of compounded versions of Novo Nordisk’s (NVO) weight loss/obesity drugs as supply conditions for the GLP-1s improve after an ...

Lexi Reed lost 312 pounds, shedding two-thirds of her body weight while battling the rare and life-threatening skin disease ...

Porous is finding new ways to measure bone health, in order to combat the bone health crisis. The company, which has been ...

A THRIFTY beauty buff has shared how she tackled her oily skin and clogged pores without forking out a fortune on fancy ...

Weight gain is common in women going through menopause. It can be caused by a variety of factors, including hormone ...